In theory, the path forward is clear: interoperability, data-driven manufacturing, and smarter scheduling powered by AI. Imagine simply inputting what you want to make — dimensions, material — and the ...
AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...
LAS VEGAS, Oct. 9, 2025 /PRNewswire/ -- Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company ("Hyperscale Data" or the "Company"), today announced that it has reduced its ...
COLUMBUS, Ohio (WCMH) — The Public Utilities Commission of Ohio rejected a bid from Amazon, Google and others to overturn AEP’s new tariff, or rate structure, specifically for data centers. Amazon and ...
Abstract: This article considers the point-to-point tracking control problem for a class of unknown nonlinear discrete-time systems with output saturation. A novel data-driven finite-iteration ...
I maintain a 'hold' rating on Recursion Pharmaceuticals due to mixed early-stage clinical data for FAP and uncertain pipeline progression. REC-617 showed an encouraging partial response in ...
So, you want to get good at LeetCode, especially using Java? It’s a common goal for a lot of us trying to land those tech jobs. This guide is all about helping you get there. We’ll go over how to ...
Boltz-2 is an open-source biomolecular model achieving near-FEP accuracy with 1000x faster predictions for structure and binding affinity. MIT and Recursion have released Boltz-2, the first ...
Beijing Zhongke Journal Publising Co. Ltd. The lead author Cheng-Zhi Qin, a professor of geographical information science (GIS) at Institute of Geographic Sciences and Natural Resources Research, ...
Structure content for AI search so it’s easy for LLMs to cite. Use clarity, formatting, and hierarchy to improve your visibility in AI results. In the SEO world, when we talk about how to structure ...
Recursion, a clinical-stage TechBio company, is set to present preliminary data from its Phase 1b/2 clinical trial, TUPELO, at the 2025 Digestive Disease Week (DDW) meeting on May 4, 2025, in San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback